InDex Pharmaceuticals is a biopharmaceutical company developing DIMS drugs to treat inflammatory diseases and cancer.
InDex Pharmaceuticals has raised €26M across 2 funding rounds, most recently a round in Feb 2014. Based in Solna, Sweden; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2014-02-01 | Other | €18M | — | View deal → |
| 2011-01-01 | Other | €8.3M | — | View deal → |
